The Pennant Group (NASDAQ:PNTG) Releases Earnings Results, Beats Expectations By $0.01 EPS

The Pennant Group (NASDAQ:PNTG) issued its earnings results on Wednesday. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.01, FiscalAI reports. The Pennant Group had a return on equity of 9.52% and a net margin of 3.15%.The firm had revenue of $229.04 million for the quarter, compared to analyst estimates of $221.96 million. The Pennant Group updated its FY 2025 guidance to 1.140-1.180 EPS.

The Pennant Group Price Performance

PNTG stock traded up $1.79 during mid-day trading on Friday, reaching $25.54. 491,421 shares of the company’s stock were exchanged, compared to its average volume of 264,890. The company has a market cap of $882.66 million, a price-to-earnings ratio of 34.05, a price-to-earnings-growth ratio of 2.07 and a beta of 1.39. The stock’s 50 day moving average is $24.74 and its 200 day moving average is $25.81. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.21 and a quick ratio of 1.21. The Pennant Group has a 12-month low of $21.18 and a 12-month high of $34.27.

Wall Street Analysts Forecast Growth

PNTG has been the topic of a number of research reports. Wells Fargo & Company cut their price objective on shares of The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 14th. Stephens reaffirmed an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research report on Thursday, October 9th. Truist Financial decreased their price objective on The Pennant Group from $32.00 to $28.00 and set a “hold” rating for the company in a report on Wednesday, July 16th. Jefferies Financial Group started coverage on The Pennant Group in a research note on Friday, October 24th. They issued a “buy” rating and a $30.00 target price on the stock. Finally, Wall Street Zen cut The Pennant Group from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $32.80.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada grew its holdings in shares of The Pennant Group by 174.5% during the first quarter. Royal Bank of Canada now owns 27,290 shares of the company’s stock worth $687,000 after buying an additional 17,347 shares in the last quarter. AQR Capital Management LLC grew its stake in The Pennant Group by 32.6% during the 1st quarter. AQR Capital Management LLC now owns 10,255 shares of the company’s stock valued at $258,000 after acquiring an additional 2,524 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in The Pennant Group by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,394 shares of the company’s stock valued at $488,000 after acquiring an additional 857 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in The Pennant Group by 4.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 81,392 shares of the company’s stock worth $2,047,000 after purchasing an additional 3,507 shares in the last quarter. Finally, Jane Street Group LLC acquired a new position in shares of The Pennant Group during the 1st quarter worth approximately $297,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.